Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement

July 13, 2020 updated by: Corin

Analysis of Clinical Outcome and Implant Migration of the Cementless Tri-Fit Total Hip Replacement System

The study will evaluate the radiographs (x-rays) of 100 patients with a TriFIT total hip at 2 weeks, 3 months, 6 months, 12 months, and yearly following surgery to see if there has been any movement or wear in the hip stem over the course of the study. The study will also record clinical data on each patient using various functional tests and questionnaires at the same intervals.

Study Overview

Detailed Description

The present study will prospectively recruit 100 patients scheduled for elective total hip replacement with Corin's TriFIT Hip System at the Ottawa Hospital - General Campus. As part of their clinical care, patients routinely undergo a clinical examination and have had radiographs taken at 2 weeks, 3 months, 6 months, 12 months, and yearly following surgery. Using specialized software, radiographs from each interval will be examined to assess femoral stem migration and joint wear patterns. Femoral stem migration will be assessed using computer-assisted software. The study will also assess the rate of implant failure during the first two post-operative years. Clinical assessments and questionnaires will also be completed during each of the follow-up intervals.

Study Type

Observational

Enrollment (Actual)

37

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Ottawa, Ontario, Canada, K1H 8L6
        • Ottawa Hospital - General Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The first 100 patients Dr. Paul Beaule undergoing a total hip replacement with Corin's TriFIT Total Hip replacement system that meet the eligibility requirements and consent to do the study.

Description

Inclusion Criteria:

  • Patients scheduled for primary, unilateral total hip replacement (THR) with no previous history of hip replacement and/or fracture surgery.
  • Patients with arthritis secondary Noninflammatory Degenerative Joint Diseases (NIDJD), including osteo/degenerative arthritis, congenital hip dysplasia, and avascular necrosis.
  • Patients who do not meet any of the exclusion criteria.

Exclusion Criteria:

  • Patients with previous fusions, acute femoral neck fractures, above knee amputations, or previous total knee replacement.
  • Patients who had previously undergone an ipsilateral hemi resurfacing, total resurfacing, total bipolar, unipolar or total hip replacement device.
  • Patients with neuropathic joints.
  • Patients who required structural bone grafts.
  • Patients with an ipsilateral girdlestone.
  • Patients who otherwise met the study criteria, but for which appropriate clinical follow-up data is not available (i.e. patients deceased prior to 2-year follow-up, patients refused to return for follow-up).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Femoral Stem Migration Radiographic Assessment
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
Femoral stem migration (in millimeters (mm)) will be assessed using computer-assisted Einzel Bild Roentgen Analyze-Femoral Component Analysis (EBRA-FCA) software and radiographs taken at each interval.
2 weeks to end of study (approximately 2 years) post-operatively
Rate of Implant Failure
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
The number of revisions will be recorded.
2 weeks to end of study (approximately 2 years) post-operatively
Radiographic Assessment of Wear in the Acetabular Components
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
Anterior-posterior (AP) and lateral radiographs from each follow-up visit will be used to assess wear of the acetabular (hip) components.
2 weeks to end of study (approximately 2 years) post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Hip Score (HHS)
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
A standardized set of questions and measurements to assess the function of the hip. It includes pain, function, range of motion (ROM), and absence of deformity.
2 weeks to end of study (approximately 2 years) post-operatively
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
A standardized set of questions and measurements to assess the function of the hip. It includes pain, stiffness, and joint function.
2 weeks to end of study (approximately 2 years) post-operatively
SF (Short Form)-12 Questionnaire
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
A subject-completed questionnaire with questions and he/she's health and well-being.
2 weeks to end of study (approximately 2 years) post-operatively
UCLA (University of California, Los Angeles) Activity Level
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
A subject-completed questionnaire which asks his/her current activity level.
2 weeks to end of study (approximately 2 years) post-operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

June 10, 2014

First Submitted That Met QC Criteria

June 10, 2014

First Posted (Estimate)

June 12, 2014

Study Record Updates

Last Update Posted (Actual)

July 14, 2020

Last Update Submitted That Met QC Criteria

July 13, 2020

Last Verified

November 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Avascular Necrosis

3
Subscribe